首页> 外文学位 >Batch and continuous production of stable dense suspensions of drug nanoparticles in a wet stirred media mill
【24h】

Batch and continuous production of stable dense suspensions of drug nanoparticles in a wet stirred media mill

机译:在湿式搅拌机中分批连续生产稳定的药物纳米颗粒致密悬浮液

获取原文
获取原文并翻译 | 示例

摘要

One way to improve the bioavailability of poorly water-soluble drugs is to reduce particle size of drug crystals down to nanoscale via wet stirred media milling. An increase in total surface area per mass loading of the drug and specific surface area as well as reduced external mass transfer resistance allow a faster dissolution of the poorly-water soluble drug from nanocrystals. To prevent aggregation of nanoparticles, polymers and surfactants are dissolved in water acting as stabilizers via adsorption onto the drug crystals.;In the last two decades, ample experimental data were generated in the area of wet stirred media milling for the production of drug nanoparticle suspensions. However, a fundamental scientific/engineering understanding of various aspects of this process is still lacking. These challenges include elucidation of the governing mechanism(s) during nanoparticle formation and physical stabilization of the nanosuspension with the use of polymers and surfactants (formulation parameters), understanding the impact of process parameters in the context of first-principle-based models, and production of truly nanosized drug particles (10--100 nm) with acceptable physical stability and minimal contamination with the media. Recirculation mode of milling operation, where the drug suspension in a holding tank continuously circulates through the stirred media mill, has been commonly used in lab, pilot, and commercial scales. Although the recirculation is continuous, the recirculation operation mode is overall a batch operation, requiring significant number of batches for a large-volume pharmaceutical product. Hence, development and investigation of a truly continuous process should offer significant advantages. To explain the impact of some of the processing parameters, stress intensity and stress number concepts were widely used in literature, which do not account for the effect of suspension viscosity explicitly. The impact of the processing parameters has not been explained in a predictive and reliable manner.;In this dissertation, a comprehensive investigation of the production of Griseofulvin nanosuspensions in a wet stirred media mill operating in both the recirculation and continuous modes has been conducted to address the aforementioned fundamental challenges. Griseofulvin has been selected as a model poorly water-soluble BCS Class II drug. Impact of various formulation parameters such as stabilizer type and loading as well as processing parameters such as rotor speed, bead loading, bead size, suspension flow rate and drug loading was studied. A major novelty of the present contribution is that the impact of processing and formulation parameters has been analyzed and interpreted using a combined experimental--theoretical (microhydrodynamic model) approach. Such a comprehensive approach allowed us to intensify the process for the production of sub-100 nm drug particles, which could not be produced with top-down approaches in the literature so far. In addition, a multi-pass mode of continuous operation was developed and the so-called "Rehbinder effect", which has not been shown for the breakage of drug particles, was also elucidated. The dissertation work (1) indicated the need for a minimum polymeric stabilizer-to-drug ratio for proper stabilization of drug nanosuspensions as dictated by polymer adsorption and synergistic interactions between a polymeric stabilizer and a surfactant, (2) demonstrated the existence of an optimum polymer concentration from a breakage rate perspective in the presence of a surfactant, which results from the competing effects of viscous dampening and enhanced steric stabilization at higher polymer concentration, (3) developed fundamental understanding of the breakage dynamics--processing--formulation relationships and rationalized preparation of a single highly drug- loaded batch (20% or higher) instead of multiple dilute batches, (4) designed an intensified process for faster preparation of sub-100 nm particles with reduced specific energy consumption and media wear (i.e. minimal drug contamination), and (5) provided first evidence for the proof of Rehbinder effect during the milling of drugs. Not only do the polymers and surfactants allow proper physical stabilization of the nanoparticles in the suspensions, but they also do facilitate drug particle breakage. This dissertation also discusses applications of nanosuspensions and practical issues encountered during wet media milling.
机译:提高水溶性差的药物的生物利用度的一种方法是通过湿式搅拌介质研磨将药物晶体的粒径减小至纳米级。药物每质量装载的总表面积和比表面积的增加以及外部传质阻力的降低允许水溶性差的药物从纳米晶体更快地溶解。为防止纳米粒子聚集,聚合物和表面活性剂通过吸附到药物晶体中而溶解在水中,起稳定剂的作用;在过去的二十年中,在湿法搅拌介质研磨领域产生了大量的实验数据,用于制备药物纳米粒子悬浮液。但是,仍然缺乏对该过程各个方面的基本科学/工程理解。这些挑战包括阐明在纳米粒子形成过程中的控制机制,以及使用聚合物和表面活性剂(配方参数)对纳米悬浮液进行物理稳定化,在基于第一原理的模型的背景下理解工艺参数的影响,以及生产具有可接受的物理稳定性和对介质的污染最小的真正纳米级药物颗粒(10--100 nm)。研磨操作的再循环模式,其中储液罐中的药物悬浮液连续不断地流过搅拌的介质研磨机,已广泛用于实验室,中试和商业规模。尽管再循环是连续的,但是再循环操作模式总体上是分批操作,对于大剂量的药品需要大量的批处理。因此,开发和研究真正连续的过程应提供显着的优势。为了解释某些加工参数的影响,应力强度和应力数概念在文献中得到了广泛使用,但并未明确考虑悬浮液粘度的影响。尚未以预测和可靠的方式解释工艺参数的影响。;本文对在循环和连续模式下运行的湿式搅拌介质磨中生产灰黄霉素的纳米悬浮液进行了全面研究,以解决上述基本挑战。灰黄霉素已被选为水溶性较差的BCS II类模型药物。研究了各种配方参数(例如稳定剂类型和负载)以及加工参数(例如转子速度,珠负载,珠大小,悬浮液流速和药物负载)的影响。本研究成果的一个主要新颖之处在于,已使用组合的实验-理论(微流体动力学模型)方法对加工和配方参数的影响进行了分析和解释。这种全面的方法使我们能够加强亚100 nm以下药物颗粒的生产过程,这是迄今为止文献中自上而下的方法无法生产的。另外,开发了连续操作的多程模式,并且还阐明了未显示出用于药物颗粒破裂的所谓的“瑞宾效应”。论文的工作(1)表明需要最小的聚合物稳定剂与药物的比例来适当稳定药物纳米悬浮液,这取决于聚合物的吸附以及聚合物稳定剂与表面活性剂之间的协同相互作用,(2)证明存在最优的在存在表面活性剂的情况下,从破损率的角度来看聚合物的浓度是由于粘滞阻尼和较高聚合物浓度下增强的空间稳定性的竞争效应所致。(3)对破损动力学-处理-配方关系和合理地制备单个高载药量批次(20%或更高)而不是多个稀释批次,(4)设计了强化工艺,可更快地制备亚100 nm以下的颗粒,同时降低了比能耗和介质磨损(即药物用量最少) (5)提供了在研磨过程中证明Rehbinder效应的最初证据o f毒品。聚合物和表面活性剂不仅可以使悬浮液中的纳米颗粒具有适当的物理稳定性,而且还可以促进药物颗粒的破碎。本文还讨论了纳米悬浮液的应用以及湿介质研磨过程中遇到的实际问题。

著录项

  • 作者

    Afolabi, Afola we mi.;

  • 作者单位

    New Jersey Institute of Technology.;

  • 授予单位 New Jersey Institute of Technology.;
  • 学科 Chemical engineering.;Science education.;Pharmaceutical sciences.
  • 学位 Ph.D.
  • 年度 2013
  • 页码 226 p.
  • 总页数 226
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号